Agent for treating allergic or hypersensitivity condition

Details Agent for treating allergic or hypersensitivity condition Agent for treating allergic or hypersensitivity condition

2007-04-24

2007-04-24

Chan, Christina (Department: 1644)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

C424S275100

Reexamination Certificate

active

09600060

ABSTRACT:
The use of an agent in the manufacture of a medicament to affect an allergic condition and/or a hypersensitivity condition is described. The agent is capable of modulating a ganglioside associated activity. The agent is not coupled to an antigen. The modulation of the ganglioside associated activity affects an allergic condition and/or a hypersensitivity condition.

REFERENCES:
patent: 5614611 (1997-03-01), Chang
patent: 5681571 (1997-10-01), Holmgren et al.
patent: WO 91/12818 (1991-09-01), None
patent: WO 97/02045 (1997-01-01), None
patent: WO 98/47529 (1998-10-01), None
patent: WO 95/10301 (1999-04-01), None
Holmgren J, Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant Am J Trop Med hyg 1994 50(5 Suppl): 42-54. Abstract.
Yamamoto et al, Mutants in the ADP-ribosyltransferase Cleft of Cholera Toxin lack darrheagenicity but retain adjuvanticity, Apr. 1997, J. Exp. Med. 185(7): 1203-1210.
Kim et al, Cholera Toxin and Cholera Toxin B Subunit Induce 1gA Switching Through the Action of TGF beta1, Feb. 1998, J. Immunology 160(3): 1198-1203.
Okahashi et al Infection and Immunity 64(5): 1516-1524.
Roitt et al, in Immunology, 2nd edition, pp. 19.1-19.3, 1989.
Patterson et al, J immunol 117(1): 97-101, Jul. 1976.
Tamura et al, Vaccine 15(2): 225-229, 1997.
Aman et al, Proc Natl Acad Sci USA 98(15): 8536-8541, Jul. 2001.
Kagan et al, Environ Health Perspect 111(2):223-5, Feb. 2003.
Wiedermann et al, International Immunology 11(7): 1131-38, 1999.
Herz et al, Methods 32(3): 271-80, Mar. 2004.
Williams et al, Proc. Natl. Acad. Sci. USA 94: 5290-5295, May 1997.
Hoynes et al, Immunology and Cell Biology 74: 180-186, 1996.
Snider et al, J Immunology 153: 647-657, 1994.
Marinaro et al, J Immunology 155: 4621-4629, 1995.
Hirai et al, Microbiol Immunol 44(4): 259-66, 2000.
Takabayashi et al, J Immunology 170: 3898-3905, 2003.
Nashar, T.O., et al., Proc. Natl. Acad. Sci. USA 93:2226-230 (1996).
Nashar, T.O., et al., Immunology 91:572-578 (1997).
Yankelevich, B., et al., J. Immunology 154:3611-3617 (1995).
Holmgren, J., et al., Proc. Natl. Acad. Sci. USA 72: 2520-2524 (1975).

Affiliated with

Also associated with

Rating

Agent for treating allergic or hypersensitivity condition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agent for treating allergic or hypersensitivity condition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for treating allergic or hypersensitivity condition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3756129